Targeted Combination Therapy Improves Erdafitinib Efficacy in Urothelial Cancer | Zendy

AI Assistant Blog Pricing

Open Access

Targeted Combination Therapy Improves Erdafitinib Efficacy in Urothelial Cancer

Author(s) -

Omotola Deborah Ogundipe,

Esther Julia Beck,

Mohamad Karim Koleilat,

Lawrence N. Kwong

Publication year - 2022

Language(s) - Uncategorized

Resource type - Conference proceedings

DOI - 10.52519/00031

Subject(s) - urothelial cancer , cancer , medicine , bladder cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Empowering knowledge with every search

About

About Careers Publisher Partners Contact Us

Learn

FAQs Blog Terms of Use Privacy Policy

Discover

Explore

Copyright Knowledge E © 2025. All Rights Reserved.